BMMSC-EVs packaged with CFZF-VPR, a zinc finger activator, successfully activated cystic fibrosis transmembrane conductance regulator (CFTR) expression in target cells, suggesting that these engineered EVs can be used as an adjunctive cellular therapeutic approach to treat cystic fibrosis [166]. The gene discussed is CFTR; the disease is cystic fibrosis.